亚洲视频免费一区,国产欧美综合一区二区,亚洲国产观看,91精品啪在线观看国产91九色,日本又黄又粗暴的gif动态图含羞,麻豆国产一区二区在线观看,中文字幕在线二区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

COVID-19 vaccine from Anhui earns conditional approval

By Wang Xiaoyu | chinadaily.com.cn | Updated: 2022-03-02 17:20
Share
Share - WeChat
Workers of Anhui Zhifei Longcom Biopharmaceutical Co Ltd check packaged drugs at the company's plant in Hefei, Anhui province, in May. [Photo/Xinhua]

China has given conditional approval for a recombinant protein subunit COVID-19 vaccine developed by domestic company Anhui Zhifei Longcom Biopharmaceutical, the National Medical Products Administration said on Wednesday.

The vaccine uses purified pieces of the virus' protein to trigger an immune response. It is the first vaccine based on this technology to be approved by the top drug regulator.

In total, five COVID-19 vaccines have been approved for public use in China so far.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US